← Evidence map

ArticleFrontiers in pharmacology2025

Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.

Seungchan Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41403449